Media Coverage header image

Media Coverage

Advanced Search
  • 07262022
    360Dx

    Even as the COVID-19 pandemic has taken center stage during the past two years, sexually transmitted diseases have also run rampant. To stem the rise in cases, they said a greater emphasis need to be placed on testing. Damian Alagia, senior medical director for advanced diagnostics and women's health at Quest Diagnostics, noted that there are many hurdles to getting a home test to commercialization, namely regulatory approval and payment models with insurers.

  • 07222022
    Forbes

    Lyme disease is an infectious disease spread by the bite of infected blacklegged ticks (also known as deer ticks) that carry the bacteria Borrelia burgdorferi, explains Harvey Kaufman, M.D., senior medical director of Medical Informatics at Quest Diagnostics. “It’s the most commonly occurring vector-borne disease in the United States,” he says.

  • 07212022
    Commercial Carrier Journal

    Overall positivity rates in urine drug tests in the transportation/warehousing industry increased 4.4% in 2020 versus 5.5% in 2021 – a relative 25% increase year over year – according to data compiled by medical lab Quest Diagnostics. Almost 130,000 truck drivers have found themselves in the Drug and Alcohol Clearinghouse as of June 1. Nearly 97,000 are still in prohibited status, and 72,000 of those haven’t even started the return to duty process.

  • 07202022
    Clinical Lab Products

    Rite Aid is collaborating with Quest Diagnostics to provide access to COVID molecular testing to help its customers detect and prevent the spread of the virus. Quest is a provider of diagnostic information services and COVID testing. The company has performed more than 69 million COVID-19 molecular tests since March 2020.

  • 07182022
    Empowered Patient Podcast

    Dr. Michael Racke is the Medical Director at Quest Advanced Neurology, which is extending the options for neurologic diagnoses by looking for biomarkers in blood tests. Michael explains, "And now, we're very much involved in developing plasma-based biomarkers to help diagnose Alzheimer's disease. Alzheimer's disease was a disorder that was initially diagnosed pathologically. You had to find the plaque and tangles in the brain at autopsy.

Show 5102550100 per page